Ofloxacin penetration into tuberculous pleural effusion

Author:

Yew W W1,Lee J1,Chan C Y1,Cheung S W1,Wong P C1,Kwan S Y1

Affiliation:

1. Tuberculosis and Chest Unit, Grantham Hospital, Aberdeen, Hong Kong.

Abstract

After 3 days of treatment with ofloxacin (300 mg given orally once daily), the drug levels in serum and pleural fluid 2 and 4 h after drug administration in patients with tuberculous pleural effusion were assessed by a rapid high-performance liquid chromatography assay. The levels in serum (mean +/- standard error of the mean [SEM]) were 4.70 +/- 0.14 and 4.63 +/- 0.09 mg/liter 2 and 4 h after administration, respectively, and the levels in pleural fluid (mean +/- SEM) were 3.82 +/- 0.09 and 4.21 +/- 0.08 mg/liter, respectively. The pleural fluid-to-serum ofloxacin ratio at 2 h was 0.82 +/- 0.02 (mean +/- SEM), and the ratio at 4 h was 0.92 +/- 0.02 (mean +/- SEM). This study demonstrated very good penetration of ofloxacin into pleural fluid in tuberculous pleuritis.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference12 articles.

1. Current concepts of tuberculous pleurisy with effusion as derived from pleural biopsy studies;Abrams W. B.;Scand. J. Respir. Dis.,1960

2. Tuberculous pleurisy;Berger H. W.;Chest,1973

3. Rapid HPLC assay of fluoroquinolones in clinical specimens;Chan C. Y.;J. Antimicrob. Chemother.,1989

4. DiffUsion of ofloxacin into human Iung tissue;Couraud L.;Drugs,1987

5. Penetration of cipr 6floxacin into human pleural fluid;Jacobs F.;Antimicrob. Agents Chemother.,1990

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Pharmacokinetics of antibiotics for pleural infection;Expert Review of Respiratory Medicine;2022-10-03

2. Role of Antimicrobial Peptides in Treatment and Prevention of Mycobacterium Tuberculosis: A Review;International Journal of Peptide Research and Therapeutics;2022-07-22

3. Penetration of Amphotericin B Lipid Formulations into Pleural Effusion;Antimicrobial Agents and Chemotherapy;2007-11

4. Efficacy of Low-Dose Ofloxacin in the Treatment of Multidrug-Resistant Tuberculosis in Indonesia;Chemotherapy;1999

5. Drug Information Rounds;Annals of Pharmacotherapy;1996-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3